Fructooligosaccharides (FOSs) are short and medium chains of fructose in which two to nine fructosyl units are bound by β 2,1 glycosidic linkages and a glucose molecule is present at the end of the chain joined by an α 1,2 glycosidic bond. Fructooligosaccharides occur in various plants such as onions, asparagus, artichokes and garlic.
Short chain FOSs (sc FOSs), such as 1 kestose, nystose and 1F β fructofuranosylnystose can also be enzymatically synthesized from sucrose. 2, 3) Fructooligosaccharides are prebiotics that have been studied in detail and they are widely used as a food ingredient. 4 6) A commercially available FOS product comprises a mixture of sc FOSs. 4) The primary physiological function of FOSs is the preferential stimulation of colonic Bifidobacteria. The effect has been confirmed in experimental animal models and in humans. 7 10) Other physiological functions of FOSs include the improvement of calcium bioavailability, the modulation of lipid metabolism and the inhibition of potential pathogen metabolism. 5, 11, 12) These functions are mainly due to the indigestibility 13) and selective fermentability of FOSs in the gastrointestinal system. 14) Studies have recently focused more on the immunomodulating effect of oligosaccharides. 15, 16) Nakamura et al . 17) reported that FOSs enhance the IgA response in the intestine of infant mice and Hosono et al . 18) also showed that the amounts of fecal IgA and of IgA secretion by Peyer s Patch cells are increased in FOS treated mice. Furthermore, Nicole et al . 19) and Pierre et al . 20) demonstrated that dietary FOSs influence gut associated lymphoid tissue.
Although beneficial colonic bacteria proliferation and short chain fatty acid production in the gut are thought to be involved in the action mechanism of FOSs on the immune system, details have not been fully established. Furthermore, whether the prebiotic and immunomodulating activities differ among FOSs in vivo and in vitro remains obscure.
We investigated the effects of 1 kestose and nystose, which are major components of a dietary FOS product, on intestinal microorganisms and on the splenocyte response to mitogenic stimulation in mice.
MATERIALS AND METHODS

Animals.
Female 6 week old BALB c mice obtained from Charles River Japan (Yokohama, Japan) were maintained at 22 24 C and around 50% relative humidity under a 12 h light dark cycle. A commercial diet (CE 2, Clea Japan, Tokyo, Japan) and water were available ad libitum. The mice were separated by body weight into three experimental groups consisting of five animals. The experimental protocol was approved by the Animal Experiment Committee of Rakuno Gakuen University and the animals were managed in accordance with the Guide for the Care and Use of Laboratory Animals of the same institution.
Bacterial strains. Lactobacillus reuteri JCM 1081, Lactobacillus murinus JCM 1717
T and Lactobacillus intestinalis JCM 7548
T purchased from the Japan Collection of Microorganisms were cultured at 37 C in MRS medium for DNA extraction.
Preparation and administration of 1-kestose and nystose. Crystalline 1 kestose and nystose were prepared by the method of Takeda et al .
3) The FOSs were dissolved in sterilized distilled water at a concentration of 10 mg mL and orally administered to mice via an intubation needle at a dose of 100 mg kg day for 14 days.
Fecal sample preparation and measurement of microorganisms and total IgA content. Fresh fecal samples were suspended in 99 volumes of sterilized saline (w v) and diluted × 10 2 . This solution was serially diluted to 10 8 and 0.1 mL aliquots were spread onto agar plates. We determined the numbers of Lactobacillus, E. coli and Bifidobacterium using LBS agar, MacConkey agar and MRS agar containing 0.3% LiCl, 0.01% neomycin sulfate and 0.0015% nalidixic acid (MRS LNN agar), 21) respectively. LBS and MRS LNN agar plates were incubated at 37 C under anaerobic conditions with AnaeroPack (Mitsubishi Gas Chemical Co., Inc. Tokyo) for 48 and 72 h, respectively. MacConkey agar plates were incubated for 24 h at 37 C under aerobic conditions. We visibly distinguished E. coli as red colonies. Supernatants of the diluted samples were stored at 80 C. Amounts of total IgA in fecal samples were assayed using a mouse IgA ELISA kit (Bethel Laboratories, Montgomery, TX, USA).
Analysis of fecal Lactobacillus by Denaturing Gradient Gel Electrophoresis (DGGE). Fecal suspensions were centrifuged at 14,000! to obtain pelleted microorganisms from which DNA was extracted and purified using a DNeasy tissue kit (Qiagen, Tokyo, Japan). The DNA was amplified using the polymerase chain reaction (PCR) with the Lactobacillus species specific primers, Lac1 and Lac2 with GC clamp (Lac2 GC), according to the program described by Walter et al . 22) We also performed DGGE according to Walter et al .
23)
Preparation of spleen cells. Three mice in each group were randomly selected and killed by cutting the carotid artery under ether anesthesia. Excised spleens were pooled and mechanically dissociated into single cell suspensions on pairs of glass slides in RPMI 1640 medium. Erythrocytes were removed with ammonium chloride and then cell suspensions were passed through a stainless mesh and washed three times with the medium. Cell viability was assessed by Trypan blue dye exclusion.
Assay of mitogenic response of spleen cells. Spleen cells (10 6 mL) were incubated with mitogen in 0.2 mL of RPMI 1640 medium containing 10% fetal bovine serum, 100 U mL of penicillin, and 100 µg mL of streptomycin in flat bottomed 96 well microplates for 3 days at 37 C under 5% CO2 in air. The Mitogens included plates pre coated with anti CD3 antibody (CBL1317, Cymbus Biotechnology, Hants, UK) plus 1 µg mL of anti CD28 antibody (sc 12727, Santa Cruz Biotechnology, Santa Cruz, CA, USA, anti CD3 CD28), concanavalin A (Con A, 1 µg mL; C 7275, Sigma, St. Louis, MO, USA) and lipopolysaccharide (LPS, 5 µg mL) from E. coli 0111:B4 (L 2630, Sigma). Three hours before the end of the culture, MTT solution (25 µL of 5µg mL) was added to the wells. The plates were centrifuged, the supernatant was removed and 100 µL of 2 propanol was added to each well. The absorbance of each well at 570 nm (A570) was then measured using a microplate reader. The result is shown as a stimulation index (S.I.) calculated by the following formula: S.I.=A570 of cell lysate with the mitogen A570 of cell lysate without the mitogen.
Assay of cytokine production. We measured the amounts of IL 2, IL 4, IL 12 and IFN γ in the supernatants of spleen cell cultures stimulated with anti CD3 CD28 or Con A for 2 days using a sandwich ELISA kit (Biosource International, Camarillo, CA, USA).
Statistical analysis. The data were analyzed by one way analysis of variance followed by Dunnett s multiple comparison test.
RESULTS
Effects of 1-kestose and nystose on fecal microorganisms.
The weight of all animals similarly increased (data not shown), but the numbers of fecal bacteria differed (Table 1). The administration of 1 kestose and nystose significantly increased the numbers of Lactobacillus on days 4 and 7, and on days 4 and 14, respectively. The number of Bifidobacterium did not significantly change with 1 kestose or nystose administration under our experimental conditions. The number of E. coli was significantly reduced by 1 kestose and nystose administration on day 14 and on day 4, respectively.
To determine whether 1 kestose and nystose could also qualitatively affect intestinal lactobacilli, we performed PCR DGGE analyses using species specific primers (Fig. 1) . Lactobacillus reuteri, Lactobacillus murinus and Lactobacillus intestinalis were the marker strains as described by Mitsuoka. 24) Each Lactobacillus species was distinguish- Each value is the mean of log10 number per gram of feces ± SD, (n=5). (p<0.05) and (p<0.01) represent the significant differences from value of control group determined by Dunnett s multiple comparison test. able in this PCR DGGE analysis (Fig. 1, lane 1) . Two amplicons corresponding to Lactobacillus reuteri and Lactobacillus intestinalis, were detected in all fecal samples. The intensity of the two amplicons obtained from feces on days 7 and 14 was similar to that determined on day 0. These results suggest that 1 kestose and nystose influenced the intestinal Lactobacillus quantitatively but not qualitatively.
IgA contents in feces of mice treated with 1-kestose and nystose. We examined the effect of 1 kestose and nystose on the fecal IgA content (Fig. 2) . The total IgA content in feces of mice treated with 1 kestose or nystose increased from day 4 and showed a significantly higher level as compared with control mice on day 7. But it decreased to nearly the same level as that of control mice on day 14.
Mitogenic response of splenocytes from mice treated with 1-kestose and nystose.
To determine the effects of 1 kestose and nystose on the systemic immune response in vivo, we examined whether the FOSs could alter the proliferation of splenocytes against several mitogenic stimuli on day 7. Both 1 kestose and nystose lowered the proliferative responses of splenocytes against anti CD3 CD28 and Con A, which are T cell mitogens, and against LPS, which is a B cell mitogen (Figs. 3A, B, C) . Splenocytes were cultured at 37 C with 5% CO2 for 48 h. Amounts of cytokines in the supernatants were measured by ELISA. Results are expressed as means of four cultures ± SD. (p 0.05) and (p 0.01) represent significant differences from value of the control group determined by Dunnett s multiple comparison test. ND: not detected.
Cytokine production from splenocytes. We confirmed the suppressive effect of 1 kestose and nystose on the splenocyte response as follows. We stimulated cells with anti CD3 CD28 or Con A and then measured the production of several cytokines that are involved in T cell proliferation and immune response modulation (Table 2 ). Both 1 kestose and nystose significantly reduced IL 2 and IL 4 production. The production of IFN γ was obviously reduced by nystose, but slightly enhanced by 1 kestose. IL 12 production was significantly reduced by administration of nystose but not influenced by 1 kestose.
DISCUSSION
Nystose and 1 kestose are the main constituents of a dietary FOS product, which is a characterized prebiotic. Many investigators have clarified the biological activities of FOSs, but mostly in a mixture. Here, we determined the effects of both 1 kestose and nystose on the intestinal microorganisms and on the immune cell response of mice. When studying their biological activities, higher doses of FOSs are generally applied to rodent models than in humans. Buddington et al . 10) reported that 4 g of neosugar day per person alters the fecal flora. On the other hand, the effects of a diet containing 25 100 g FOSs kg on mouse intestinal immunity have been determined. 17 19) However, our preliminary examination found that 20 100 mg kg of 1 kestose per day altered the Con A response of mouse splenocytes (data not shown). We therefore used a dose of 100 mg kg day of FOS and found that the immune cell response and the intestinal microorganisms were indeed affected.
A dietary FOS product containing 1 kestose and nystose dominantly increases intestinal Lactobacillus in mice 18) and rats. 25) Our observations suggested that both the FOSs had Lactobacillus promoting activity. Our preliminary experiments showed that 1 kestose and nystose were fermentable by Lb. intestinalis and Lb. reuteri isolates obtained from mouse feces (data not shown). If the various intestinal Lactobacillus species can utilize FOSs differently, then the Lactobacillus flora might change. However, neither 1 kestose nor nystose altered the fecal Lactobacillus ratio as assessed by PCR DGGE using a Lactobacillus specific primer. The abilities of Lb. intestinalis and Lb. reuteri in the mouse intestinal tract to utilize 1 kestose and nystose were essentially identical.
A dietary FOS product can stimulate intestinal IgA secretion. We confirmed that 1 kestose and nystose can enhance IgA secretion as the level increased in the middle of our FOS administration schedule. Our results were very similar to those of Nakamura et al . 17) and of Hosono et al ., 18) although the dose of the FOS in our study was much lower than theirs. Hosono et al . 18) suggested that stimulation of intestinal IgA secretion with FOSs correlates with an increased proportion of intestinal Gram positive bacteria such as Lactobacillus. In our result the enhancement of IgA content by 1 kestose and nystose was shown from day 4 to 7 correlating with the increase of Lactobacillus. The enhancement of IgA content by 1 kestose and nystose, however, was not maintained on day 14. The feces showed slight diarrhea on day 14. Dilution of the fecal IgA content by the diarrhea would be partly influenced by the diminishment of the effect of 1 kestose and nystose. Additionally, the unresponsiveness towards the resident microflora was thought to be important to permit their successful colonization.
26) The enhancement of the intestinal immune responses by the commensal microorganisms, such as Lactobacillus might not last for a long time.
We found that both nystose and 1 kestose reduced the splenocyte mitogenic response and Th1 (IL 2, IFN γ and IL 12) and Th2 (IL 4) oriented cytokine secretion. The reduction of splenocyte proliferation with T cell mitogens is thought to be due to the decrease of IL 2 secretion. Hosono et al . 18) reported that a dietary FOS product supplementation could suppress Th 2 type antibody in the sera, but not Th 1 type antibody. The dose amount and period, and the type of FOS sample might account for the difference between our results and theirs. Although our results are not fully consistent with their observation, it was suggested that both 1 kestose and nystose can probably modulate the systemic immune response to suppress allergic and inflammatory reactions.
Interestingly, nystose suppressed cytokine secretion more than 1 kestose whereas the Lactobacillus promoting activities of the FOSs did not significantly differ. Anti CD3 antibody plus anti CD28 antibody can stimulate T cells directly to secrete IL 2, whereas Con A stimulation requires some accessory cells, such as dendritic cells or macrophages for IL 2 secretion from T cells. 27, 28) Nystose administration could suppress cytokine secretion from splenocytes with both types of stimulation. IL 12 is one of the Th1 oriented cytokines secreted mainly from dendritic cells and macrophages with various types of stimulation. 29) Nystose, but not 1 kestose, significantly reduced IL 12 secretion, hence nystose administration can influence the function of dendritic cells macrophages more strongly than 1 kestose. Since IL 12 is a potent IFN γ inducer against various cells, 29) the decrease of IFN γ secretion by nystose administration may be involved in the down regulated IL 12 secretion. Since nystose has a higher suppressive activity for cytokine secretion, the increase of the ratio of nystose in a dietary FOS product might enhance the immunomodulating activity.
Hosono et al . 18) suggested that the increase of Gram positive bacteria, such as Lactobacillus, induced by a dietary FOS product can affect not only the intestinal immune response but also the systemic one. It would be likely that the effects of 1 kestose and nystose on the systemic immune response are strongly concerned with the increase of Lactobacillus. But, the reason why the suppressive effect of nystose is higher than that of 1 kestose can t be explained by only the Lactobacillus number. Zdunczyk et al . 30) reported that a nystose rich FOS preparation increased volatile fatty acid production, which is a byproduct of fermentation by Gram positive bacteria, in the caecum of rats, when compared with a 1 kestose rich preparation. Although the effect of the two FOS preparations on the microflora or the immune system was not described in their report, it is mostly probable that 1 kestose and nystose show different activities on the microflora.
Additional studies are required to determine which intestinal microbes other than Lactobacillus and Bifidobacterium are involved in the systemic immunomodulating activity of 1 kestose and nystose, and whether the FOSs can directly influence the immune cells.
Recent clinical and experimental data suggest that inflammatory bowel diseases can be prevented by inulin and FOSs.
31) Many types of cytokines are involved in the inflammatory bowel reaction in experimental models, such as the dextran sulfate colitis or trinitrobenzene sulfonic acid models.
32,33) Strober et al . 34) noted that IFN γ and TGF β play critical roles in proinflammatory and in anti inflammatory reactions, respectively, and that the inhibition of Th1 oriented cytokines such as IFN γ and or IL 12 might be central to the treatment of inflammatory bowel disease. Cherbut et al . 35) reported that FOSs reduce intestinal inflammatory activity mainly by increasing the amount of intestinal lactic acid bacteria. Although further studies are still required to understand the anti inflammatory activity of FOSs, their ability to reduce cytokine secretion might be important to prevent the development of bowel inflammation.
In conclusion, 1 kestose and nystose, which are major components of a dietary FOS product, can modulate the intestinal microorganism flora through mechanisms such as increasing Lactobacillus and or decreasing E. coli, of IgA production in the intestinal tract, and suppressing cytokine production. However, these components have different degrees of effectiveness. The results of the present study revealed more details of the biological activities of 1 kestose and nystose, and also indicated that the ratios of the FOSs can be changed to improve their activities.
